NCT04277156 - L Rhamnosus ATCC 53103 & L Reuteri DSM 29063 Compared With L Rhamnosus ATCC 53103 for Preventing AAD in Children | Biotech Hunter

Enrollment

892

Participants

Timeline

Start Date

February 29, 2020

Primary Completion Date

May 31, 2023

Study Completion Date

December 31, 2023

Conditions

Antibiotic-associated Diarrhea

Interventions

DIETARY_SUPPLEMENT

Lactobacillus rhamnosus ATCC 53103 & Lactobacillus reuteri DSM 29063

7 drops contain Lactobacillus rhamnosus GG 5x10\^9 CFU; and Lactobacillus reuteri 1x10\^8 CFU.

DIETARY_SUPPLEMENT

L rhamnosus ATCC 53103

5 drops contain Lactobacillus rhamnosus 5x10\^9 CFU.

Trial Locations (1)

Department of Paediatrics, St. Hedwig of Silesia Hospital, Trzebnica